The seroprevalence of parvovirus B19 antibody in blood donors at the National Blood Transfusion Center in Kinshasa.

Alain Chabo ByaeneZakayi Pius KabututuDina Moustafa Abou RayiaMohamed Mohamed Adel El-Sokkary

Published in: Journal of medical virology (2019)

This research showed that recipients of blood and blood products in Kinshasa are at a high risk (5.3%) of transfusion-transmitted PVB19 infection. Therefore, the implementation of PVB19 nucleic acid testing assays capable of detecting all PVB19 genotypes and discard donations with high titer PVB19 DNA for blood products seems to be necessary.

Keyphrases

nucleic acid
quality improvement
primary care
healthcare
cardiac surgery
circulating tumor